High prevalence of non-productive FeLV infection in necropsied cats and significant association with pathological findings

Veterinary Immunology and Immunopathology

Volumn 136, Issue 1-2, 2010, Pages 71-80

  Suntz, M ^a   Failing, K ^a   Hecht, W ^a   Schwartz, D ^a   Reinacher, M ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Bone marrow; Feline; Immunohistochemistry; Non productive FeLV infection; Provirus; Semi nested PCR

Indexed keywords

VIRUS ANTIGEN;

AGRANULOCYTOSIS; ANEMIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTERIOSCLEROSIS; ARTICLE; ATELECTASIS; AUTOPSY; BONE MARROW; BREAST ADENOCARCINOMA; CAT; FATTY LIVER; FELINE LEUKEMIA VIRUS; FELINE LEUKEMIA VIRUS INFECTION; FEMALE; GLOMERULONEPHRITIS; IMMUNOHISTOLOGY; INTERSTITIAL NEPHRITIS; KIDNEY CYST; LUNG ADENOMA; LYMPHOID HYPERPLASIA; LYMPHOSARCOMA; MALE; MENINGIOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; SQUAMOUS CELL CARCINOMA; VIRUS INFECTION;

ANIMALS; ANTIGENS, VIRAL, TUMOR; BASE SEQUENCE; CAT DISEASES; CATS; DNA PRIMERS; DNA, VIRAL; FEMALE; GERMANY; IMMUNOENZYME TECHNIQUES; LEUKEMIA VIRUS, FELINE; MALE; POLYMERASE CHAIN REACTION; PROVIRUSES; RETROVIRIDAE INFECTIONS; TUMOR VIRUS INFECTIONS;

ANIMALIA; FELIDAE; FELINE LEUKEMIA VIRUS;

EID: 77953612813     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.02.014     Document Type: Article

References (76)

1. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215:403-410.
2. Arjona A., Barquero N., Domenech A., Tejerizo G., Collado V.M., Toural C., Martin D., Gomez-Lucia E. Evaluation of a novel nested PCR for the routine diagnosis of feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV). J. Feline Med. Surg. 2006, 9:14-22.
3. Arjona A., Escolar E., Soto I., Barquero N., Martin D., Gomez-Lucia E. Seroepidemiological survey of infection by feline leukemia virus and immunodeficiency virus in Madrid and correlation with some clinical aspects. J. Clin. Microbiol. 2000, 38:3448-3449.
4. Bandecchi P., Dell'Omodarme M., Magi M., Palamidessi A., Prati M.C. Feline leukemia virus (FeLV) and feline immunodeficiency virus infections in cats in the Pisa district of Tuscany, and attempts to control FeLV infection in a colony of domestic cats by vaccination. Vet. Rec. 2006, 188:555-557.
5. Benveniste R.E., Todaro G.J. Evolution of C-type viral genes: inheritance of exogenously acquired viral genes. Nature 1974, 252:456-459.
6. Berry B.T., Ghosh A.K., Kumar D.V., Spodick D.A., Roy-Burman P. Structure and function of endogenous feline leukemia virus long terminal repeats and adjoining regions. J. Virol. 1988, 62:3631-3641.
7. Casey J.W., Roach A., Mullins J.I., Burck K.B., Nicolson M.O., Gardner M.B., Davidson N. The U3 portion of feline leukemia virus identifies horizontally acquired proviruses in leukemic cats. Proc. Natl. Acad. Sci. 1981, 78:7778-7782.
8. Coffin J.M. Structure, replication and recombination of retrovirus genomes: some unifying hypotheses. J. Gen. Virol. 1979, 42:1-26.
9. Cotter S.M. Feline viral neoplasia. Infectious Diseases of the Dog and Cat 1998, 71-84. W.B. Saunders Company, Philadelphia. C. Greene (Ed.).
10. Cotter S.M., Hardy W.D., Essex M. Association of feline leukemia virus with lymphosarcoma and other disorders in the cat. J. Am. Vet. Med. Assoc. 1975, 166:449-454.
11. Cullen C.L., Haines D.M., Jackson M.L., Peiffer R.L., Grahn B.H. The use of immunohistochemistry and the polymerase chain reaction for detection of feline leukemia virus and feline sarcoma in six cases of feline ocular sarcoma. Vet. Ophthalmol. 1998, 1:189-193.
12. Dorny P., Speybroeck N., Verstraete S., Backe M., De Becker A., Berkvens D., Vercruysse J. Serological survey of Toxoplasma gondii, feline immunodeficiency virus and feline leukaemia virus in urban stray cats in Belgium. Vet. Rec. 2002, 151:626-629.
13. Ellis J.A., Jackson M.L., Bartsch R.C., McGill L.G., Martin K.M., Trask B.R., Haines D.M. Use of immunohistochemistry and polymerase chain reaction for detection of oncornaviruses in formalin-fixed, paraffin-embedded fibrosarcomas from cats. J. Am. Vet. Med. Assoc. 1996, 209.
14. Essex M., Cotter S.M., Hardy W.D., Hess P., Jarrett W., Jarrett O., Mackey L., Laird H., Perryman R., Olsen G., Yohn D.S. Feline oncornavirus-associated cell membrane antigen. IV. Antibody titers in cats with naturally occurring leukemia, lymphoma, and other diseases. J. Natl. Cancer Inst. 1975, 55:463-467.
15. Fujino Y., Ohno K., Tsujimoto H. Molecular pathogenesis of feline leukemia virus-induced malignancies: insertional mutagenesis. Vet. Immunol. Immunopathol. 2008, 123:138-143.
16. Fulton R., Plumb M., Shield L., Neil J.C. Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus. J. Virol. 1990, 64:1675-1682.
17. Favrot C., Wilhelm S., Grest P., Meli M.L., Hofmann-Lehmann R., Kipar A. Two cases of FeLV-associated dermatoses. Vet. Dermatol. 2005, 16:407-412.
18. Francis D.P., Essex M., Cotter S.M., Gutensohn N., Jakowski R., Hardy W.D. Epidemiologic association between virus-negative feline leukemia and the horizontally transmitted feline leukemia virus. Cancer Lett. 1981, 12:37-42.
19. Francis D.P., Essex M., Jakowski R.M., Cotter S.M., Lerer T.J., Hardy W.D. Increased risk for lymphoma and glomerulonephritis in a closed population of cats exposed to feline leukemia virus. Am. J. Epidemiol. 1980, 111:337-346.
20. Ghosh S.K., Roy-Burman P., Faller D.V. Long terminal repeat regions from exogenous but not endogenous feline leukemia virus transactivate cellular gene expression. J. Virol. 2000, 74:9742-9748.
21. Goff S.P. Retroviridae. The retroviruses and their replication. Fields' Virology 2001, 1871-1940. Lippincott Williams & Wilkins, Philadelphia. D. Knipe, P.M. Howley (Eds.).
22. Hardy W.D., Hess P.W., MacEwen E.G., McLelland A.J., Zuckermann E.E., Essex M., Cotter S.M., Jarrett O. Biology of feline leukemia virus in the natural environment. Cancer Res. 1976, 36:582-588.
23. Hardy W.D., McClelland A.J., Zuckerman E.E., Snyder H.W., MacEwen E.G., Francis D., Essex M. Development of virus non-producer lymphosarcomas in pet cats exposed to FeLV. Nature 1980, 288:90.
24. Hayes K.A., Rojko J.L., Mathes L.E. Incidence of localized feline leukaemia virus infection in cats. Am. J. Vet. Res. 1992, 53:604-607.
25. Herring E.S., Troy G.C., Toth T.E., Forrester S.D., Weigt L.A., Herring I.P. Detection of feline leukaemia virus in blood and bone marrow of cats with varying suspicion of latent infection. J. Feline Med. Surg. 2001, 3:133-141.
26. Hirschberger, J., 1987, Herstellung und Charakterisierung monoklonaler Antikörper gegen T-Lymphocyten des Huhnes, in German. Vet. Med. Diss., Giessen.
27. Hofmann-Lehmann R., Huder J.B., Gruber S., Boretti F., Sigrist B., Lutz H. Feline leukemia provirus load during the course of experimental infection and in naturally infected cats. J. Gen. Virol. 2001, 82:1589-1596.
28. Hofmann-Lehmann R., Tandon R., Borretti F.S., Meli M.L., Willi B., Cattori V., Gomes-Keller M.A., Ossent P., Golder M.C., Flynn J.N., Lutz H. Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays. Vaccine 2006, 24:1087-1094.
29. Hoover E.A., Mullins E.A. Feline leukemia virus infection and diseases. J. Am. Vet. Med. Assoc. 1991, 199:1287-1297.
30. Jackson M.L., Haines D.M., Meric S.M., Misra V. Feline leukemia virus detection by immunohistochemistry and polymerase chain reaction in formalin-fixed, paraffin-embedded tumor tissue from cats with lymphosarcoma. Can. J. Vet. Res. 1993, 57:269-276.
31. Jackson M.L., Haines D.M., Taylor S.M., Misra V. Feline leukemia virus detection by ELISA and PCR in peripheral blood from 68 cats with high, moderate, or low suspicion of having FeLV-related disease. J. Vet. Diagn. Invest. 1996, 8:25-30.
32. Jarrett W.F., Martin W.B., Crighton G.W., Dalton R.G., Stewart M.F. Transmission experiments with leukemia (lymphosarcoma). Nature 1964, 202:566-567.
33. Jarrett W.F., Crawford E.M., Martin W.B., Davie F. A virus-like particle associated with leukemia (lymphosarcoma). Nature 1964, 202:567-569.
34. Jun K., Lee S., Shin H. Insertion of a retroviral solo long terminal repeat in mdr-3 locus disrupts mRNA splicing in mice. Mamm. Genome 2000, 11:843-848.
35. Knotek Z., Hajkova P., Svoboda M., Toman M., Raska V. Epidemiology of feline leukaemia and feline immunodeficiency virus infections in the Czech Republic. Zentralbl. Veterinärmed. B 1999, 46:665-671.
36. Kovacevic S., Kipar A., Kremendahl J., Teebken-Schuler D., Grant C.K., Reinacher M. Immunohistochemical diagnosis of feline leukemia virus infection in formalin-fixed tissue. Eur. J. Vet. Pathol. 1997, 3:13-19.
37. Kumar V.D., Berry B.T., Roy-Burman P. Nucleotide sequence and distinctive characteristics of the env gene of endogenous feline leukemia provirus. J. Virol. 1989, 63:2379-2384.
38. Lafrado L.J., Dezzutti C.S., Lewis M.G., Olsen R.G. Immunodeficiency in latent feline leukemia virus infections. Vet. Immunol. Immunopathol. 1989, 21:39-46.
39. Lafrado L.J., Lewis M.G., Mathes L.E., Olsen R.G. Suppression of in vitro neutrophil function by feline leukaemia virus (FeLV) and purified FeLV-p15E. J. Gen. Virol. 1987, 68:507-513.
40. Levy L.S., Gardner M.B., Casey J.W. Isolation of a feline leukaemia provirus containing the oncogene myc from a feline lymphosarcoma. Nature 1984, 308:853-855.
41. Levy L.S., Lobelle-Rich P.A. Insertional mutagenesis of flvi-2 in tumors induced by infection with LC-FeLV, a myc-containing strain of feline leukemia virus. J. Virol. 1992, 69:2885-2892.
42. Levy L.S., Starkey C.R., Prabhu S., Lobelle-Rich P.A. Cooperating events in lymphomagenesis mediated by feline leukemia virus. Leukemia 1997, 11:239-241.
43. Linenberger M.L., Abkowitz J.L. In vivo infection of marrow stromal fibroblasts by feline leukemia virus. Exp. Hematol. 1992, 20:1022-1027.
44. Lutz H., Castelli I., Ehrensperger F., Pospischil A., Rosskopf M., Siegl G., Grob M., Martinod S. Panleukopenia-like syndrome of FeLV caused by co-infection with FeLV and feline panleukopenia virus. Vet. Immunol. Immunopathol. 1995, 46:21-33.
45. Madewell B.R., Jarrett O. Recovery of feline leukaemia virus from non-viraemic cats. Vet. Rec. 1983, 112:339.
46. Malik R., Kendall K., Cridland J., Coulston S., Stuart A.J., Snow D., Love D.N. Prevalences of feline leukaemia virus and feline immunodeficiency virus infections in cats in Sydney. Aust. Vet. J. 1997, 75:323-327.
47. Mathes L.E., Olsen R.G., Hebebrand L.C., Hoover E.A., Schaller J.P. Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein. Nature 1978, 274:687-689.
48. McClelland A.J., Hardy W.D., Zuckermann E.E. Prognosis of healthy FeLV infected cats. Feline Leukemia Virus 1980, 122-126. Elsevier North Holland, New York. W.J. Hardy, M. Essex, A.J. McClelland (Eds.).
49. Merezak C., Pierreux C., Adam E., Lemaigre F., Rousseau C.G., Calomme C., Van Lint C., Christophe D., Kerkhofs P., Burny A., Kettmann R., Willems L. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency. J. Virol. 2001, 75:6977-6988.
50. Muirden A. Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus and feline coronavirus in stray cats sent to an RSPCA hospital. Vet. Rec. 2002, 150:621-625.
51. Neil J.C., Hughes D., McFarlane R., Wilkie N.M. Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature 1984, 308:814-820.
52. Olsen R.G., Lewis M.G., Lafrado L.J., Mathes L.E., Haffer K., Sharpee R. Feline leukemia virus: current status of the feline induced immune depression and immunoprevention. Cancer Metast. Rev. 1987, 6:243-260.
53. Pacitti A.M., Jarrett O. Duration of the latent state in feline leukemia virus infections. Vet. Rec. 1985, 117:472-474.
54. Pedersen N.C., Meric S.M., Ho E., Johnson L., Plucker S., Theilen G. The clinical significance of latent feline leukemia virus infection in cats. Feline Pract. 1984, 14:32-48.
55. Pinches M.D., Helps C.R., Gruffydd-Jones T.J., Egan K., Jarrett O., Tasker S. Diagnosis of feline leukaemia virus infection by semi-quantitative real-time polymerase chain reaction. J. Feline Med. Surg. 2006, 9:8-13.
56. Post J., Warren L. Reactivation of latent feline leukemia virus. Feline Leukemia Virus 1980, 151-155. Elsevier North Holland, New York. W.J. Hardy, M. Essex, A.J. McClelland (Eds.).
57. Reinacher M., Wittmer G., Koberstein H., Failing K. Untersuchungen zur Bedeutung der FeLV-Infektion für Erkrankungen bei Sektionskatzen. Berl. Münch. Tierärztl. Wschr. 1995, 108:58-60.
58. Reinacher M. Feline leukemia virus associated enteritis-a condition with features of feline panleukopenia. Vet. Pathol. 1987, 24:1-4.
59. Reinacher M., Theilen G.H. Frequency and significance of feline leukemia virus infection in necropsied cats. Am. J. Vet. Res. 1987, 48:939-945.
60. Rice J.B., Olsen R.G. Feline oncovirus-associated cell membrane antigen and feline leukemia virus group-specific antigen expression in bone marrow and serum. J. Natl. Cancer Inst. 1981, 66:737-743.
61. Rojko J.L., Hoover E.A., Mathes L.E., Olsen R.G., Schaller J.P. Pathogenesis of experimental feline leukemia virus infection. J. Natl. Cancer Inst. 1979, 63:759-765.
62. Rojko J.L., Hoover E.A., Quackenbush S.L., Olsen R.G. Reactivation of latent feline leukemia virus infection. Nature 1982, 298:385-388.
63. Rojko J.L., Olsen R.G. The immunobiology of the feline leukemia virus. Vet. Immunol. Immunopathol. 1984, 6:107-165.
64. Schniewind A., Reinacher M., Theilen G.H., Unger H., Weiss E. Vorkommen von Infektionen mit dem Feline Leukämie-Virus (FeLV) im Raum Gießen und Augsburg. Kleintierpraxis 1983, 28:361-370.
65. Sninsky J.J. The polymerase chain reaction (PCR): a valuable method for retroviral detection. Lymphology 1990, 23:92-97.
66. Stewart M.A., Warnock M., Wheeler A., Wilkie N., Mullins J.I., Onions D.E., Neil J.C. Nucleotide sequence of a feline leukaemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J. Virol. 1986, 56:701-710.
67. Svoboda J., Hejnar J., Geryk J., Elleder D., Vernerova Z. Retroviruses in foreign species and the problem of provirus silencing. Gene 2000, 261:181-188.
68. Svoboda J., Popovic M., Sainerova H., Mach O., Shoyab M., Baluda M.A. Incomplete viral genome in a non-virogenic mouse tumour cell line (RVP3) transformed by Prague strain of avian sarcoma virus. Int. J. Cancer 1977, 19:851-858.
69. Swenson C.L., Kociba G.J., Mathes L.E., Hand P.J., Neer C.A., Hayes K.A., Olsen R.G. Prevalence of disease in nonviremic cats previously exposed to feline leukemia virus. J. Am. Vet. Med. Assoc. 1990, 196:1049-1052.
70. Swenson C.L., Kociba G.J., O'Keefe D.A., Crisp M.S., Jacobs R.M., Rojko J.L. Cyclic hematopoiesis associated with feline leukemia virus infection in two cats. J. Am. Vet. Med. Assoc. 1987, 191:93-96.
71. Theilen G.H., Kawakami T.G., Rush J.D., Munn R.J. Replication of cat leukemia virus in cell suspension culture. Nature 1969, 222:589-590.
72. Torres A.N., O'Halloran K.P., Larson L.J., Schultz R.D., Hoover E.A. Development and application of a quantitative real-time PCR assay to detect feline leukemia virus RNA. Vet. Immunol. Immunopathol. 2008, 123:81-89.
73. Torres A.N., Mathiason C.K., Hoover E.A. Re-examination of feline leukemia virus: host relationships using real-time PCR. Virology 2005, 332:272-283.
74. Tobey J.C., Houston D.M., Breur G.J., Jackson M.L., Stubbington D.A. Cutaneous T-cell lymphoma in a cat. J. Am. Vet. Med. Assoc. 1994, 204:606-609.
75. Tsatsanis C., Fulton R., Nishigaki K., Tsujimoto H., Levy L., Terry A., Spandidos D., Onions D., Neil J.C. Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement. J. Virol. 1994, 68:8296-8303.
76. Uthmann A., Moestl K., Zetner K., Steurer I., Tschachler E. Detection of sequences of feline leukemia virus in chronically inflamed oral tissue of FeLV-non-viremic cats by using polymerase chain reaction. Wien. Tierärztl. Mschr. 1996, 83:195-198.